$CYDY ICYMI http://crweworld.com/article/news-provided-by-business-wire/2212028/leronlimab-350-mg-weekly-use-for-14-weeks-in-open-label-arm-of-nash-trial-produces-fibrosis-reduction-as-high-as-93-msec-amongst-first-15-patients-with-average-reduction-of-24-msec